Pacific Biosciences of California, Inc. Share-based Payment Arrangement, Amount Capitalized
Pacific Biosciences of California, Inc. (PACB) reported Share-based Payment Arrangement, Amount Capitalized of $400.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Share-Based Payment Arrangement
us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount · last filed 2026-02-25
- Pacific Biosciences of California, Inc. share-based payment arrangement, amount capitalized for fiscal 2025 was $400.00K, a 33.33% decline from fiscal 2024.
- Pacific Biosciences of California, Inc. share-based payment arrangement, amount capitalized for fiscal 2024 was $600.00K, a 0.00% change from fiscal 2023.
- Pacific Biosciences of California, Inc. share-based payment arrangement, amount capitalized for fiscal 2023 was $600.00K, a 14.29% decline from fiscal 2022.
- Pacific Biosciences of California, Inc. share-based payment arrangement, amount capitalized for fiscal 2022 was $700.00K, a 22.22% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Amount Capitalized 12 month | Share-based Payment Arrangement, Amount Capitalized 12 month as first filed |
|---|---|---|
| 2025-12-31 | $400.00K 10-K · filed 2026-02-25 | |
| 2024-12-31 | $600.00K 10-K · filed 2026-02-25 | |
| 2023-12-31 | $600.00K 10-K · filed 2025-03-17 | |
| 2022-12-31 | $700.00K 10-K · filed 2024-02-28 | |
| 2021-12-31 | $900.00K 10-K · filed 2023-02-28 | |
| 2020-12-31 | $300.00K 10-K · filed 2022-02-28 | |
| 2019-12-31 | $300.00K 10-K · filed 2021-02-26 | |
| 2018-12-31 | $700.00K 10-K · filed 2020-02-28 | |
| 2017-12-31 | $400.00K 10-K · filed 2019-02-26 | $441.00K 10-K · filed 2018-02-26 |
| 2016-12-31 | $389.00K 10-K · filed 2018-02-26 | |
| 2015-12-31 | $315.00K 10-K · filed 2017-03-06 | |
| 2014-12-31 | $225.00K 10-K · filed 2016-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |